Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giora Feuerstein

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
Inflammation and stroke: therapeutic effects of adenoviral expression of secretory Leukocyte Protease InhibitorGiora Feuerstein
Stroke|September 11, 2002
Immune tolerance and stroke: a turning pointNili Feuerstein, Steven Goldman, Giora Feuerstein
European Journal of Pharmacology|August 2, 2003
Characterization of binding kinetics of [3H]Tyr-D-Arg2-Phe-Sar4 at opioid receptorsStefan Vonhof, Giora Feuerstein, Anna-Leena Sirén
Thrombosis Research|May 22, 2003
Cloning and expression of rat coagulation factor VIIShobha Seetharam, Kathleen Murphy, Charity Atkins, et al.
Biomarkers in Medicine|May 19, 2010
Biomarkers in the development of novel disease-modifying therapies for osteoarthritisStephanie Parsons, Salvatore Alesci, Giora Feuerstein, et al.
Biochemical Pharmacology|June 23, 2009
A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and developmentLei Zhao, Weijun Jin, Daniel Rader, et al.
International Journal of Nanomedicine|May 30, 2017
Bitistatin-functionalized fluorescent nanodiamond particles specifically bind to purified human platelet integrin receptor α<sub>IIb</sub>β<sub>3</sub> and activated plateletsCezary Marcinkiewicz, Jonathan A Gerstenhaber, Mark Sternberg, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|July 5, 2008
Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinicMark Day, Fuat Balci, Hong I Wan, et al.
Journal of Proteome Research|November 12, 2009
Stoichiometric quantification of Akt phosphorylation using LC-MS/MSAbdelmadjid Atrih, Dan Turnock, Grant Sellar, et al.
Experimental Neurology|March 18, 2004
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotectionSusan C Fagan, David J Edwards, Cesar V Borlongan, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
Inflammation and stroke: therapeutic effects of adenoviral expression of secretory Leukocyte Protease InhibitorGiora Feuerstein
Stroke|September 11, 2002
Immune tolerance and stroke: a turning pointNili Feuerstein, Steven Goldman, Giora Feuerstein
European Journal of Pharmacology|August 2, 2003
Characterization of binding kinetics of [3H]Tyr-D-Arg2-Phe-Sar4 at opioid receptorsStefan Vonhof, Giora Feuerstein, Anna-Leena Sirén
Thrombosis Research|May 22, 2003
Cloning and expression of rat coagulation factor VIIShobha Seetharam, Kathleen Murphy, Charity Atkins, et al.
Biomarkers in Medicine|May 19, 2010
Biomarkers in the development of novel disease-modifying therapies for osteoarthritisStephanie Parsons, Salvatore Alesci, Giora Feuerstein, et al.
Biochemical Pharmacology|June 23, 2009
A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and developmentLei Zhao, Weijun Jin, Daniel Rader, et al.
International Journal of Nanomedicine|May 30, 2017
Bitistatin-functionalized fluorescent nanodiamond particles specifically bind to purified human platelet integrin receptor α<sub>IIb</sub>β<sub>3</sub> and activated plateletsCezary Marcinkiewicz, Jonathan A Gerstenhaber, Mark Sternberg, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|July 5, 2008
Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinicMark Day, Fuat Balci, Hong I Wan, et al.
Journal of Proteome Research|November 12, 2009
Stoichiometric quantification of Akt phosphorylation using LC-MS/MSAbdelmadjid Atrih, Dan Turnock, Grant Sellar, et al.
Experimental Neurology|March 18, 2004
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotectionSusan C Fagan, David J Edwards, Cesar V Borlongan, et al.
Pageof 2